Arthrex is sponsoring a clinical trial to study a non-surgical alternative treatment for osteoarthritis. The clinical trial will include 90 patients treated by a group of knee specialists considered experts in the field of therapeutic biologics. Each specialist and the associated medical facility have been approved by Arthrex and the facility’s Institutional Review Board.
If you take part in the trial, you will be randomly assigned to receive one of two treatments described below.
- ACP treatment injections
- Normal saline injections
To skip ahead to a particular question, click the questions below: